OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.630
-0.380 (-12.62%)
At close: Nov 13, 2026, 4:00 PM EST
2.610
-0.020 (-0.76%)
After-hours: Nov 13, 2026, 4:10 PM EST
OnKure Therapeutics Employees
OnKure Therapeutics had 45 employees as of December 31, 2025. The number of employees decreased by 1 or 2.17% compared to the previous year. That makes OnKure Therapeutics the 35,559th largest employer in the world and 4,766th in the United States.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.17%
Revenue / Employee
n/a
Profits / Employee
-$1,374,489
Market Cap
106.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -1 | -2.17% |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Jun 30, 2024 | 50 | - | - |
| Mar 31, 2024 | 49 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Molecular Partners AG | 134 |
| Adagene | 128 |
| Immunic | 100 |
| ImmuCell | 73 |
| NovaBridge Biosciences | 30 |
| Unicycive Therapeutics | 22 |
| Outlook Therapeutics | 17 |
OKUR News
- 10 days ago - OnKure Therapeutics reports Q3 EPS (36c), consensus (41c) - TheFly
- 11 days ago - OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights - GlobeNewsWire
- 11 days ago - OnKure Therapeutics Quarterly report: Q3 2026 - Filings
- 11 days ago - OnKure Therapeutics Earnings release: Q3 2026 - Filings
- 2 months ago - OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewsWire
- 3 months ago - OnKure Therapeutics price target lowered to $14 from $30 at Oppenheimer - TheFly
- 3 months ago - OnKure Therapeutics reports Q2 EPS (31c), consensus (54c) - TheFly
- 3 months ago - OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights - GlobeNewsWire